Epigenomic Analyses Identify FOXM1 As a Key Regulator of Anti-Tumor Immune Response in Esophageal Adenocarcinoma https://www.biorxiv.org/content/10.1101/2023.07.28.551066v1?med=mas
Epigenomic Analyses Identify FOXM1 As a Key Regulator of Anti-Tumor Immune Response in Esophageal Adenocarcinoma https://www.biorxiv.org/content/10.1101/2023.07.28.551066v1?med=mas